High Value Products From Trimming Waste (Hvp-T)

Technology Outline

• High grade gelatin and protein hydrolysate are the products made under this technology.
• Developed high grade gelatin can be used as raw materials for food, pharma and laboratory applications.
• Developed protein hydrolysate have multiple usage, they can be used in leather, agriculture or animal feed applications.

Salient Features/ Highlights/ Advantages

• Complete utilization of trimming waste to make high value products within 48 hrs.
• Simple, innovative and cost effective technology
• Holistic and a closed loop process for the extraction of gelatin
• High grade Gelatin with high gel strength > 250 g

Commercialization Status/ Techno - Economics:

• Status of commercialization : This technology has been already commercialized
• Licensed to three clients
• Major Raw Materials to be utlilized: Hide/ Skin trimming waste from Tanneries
• Validation level: Validated at Pilot scale
• Handholding support: Training, Demonstration, Technology Document, Trouble Shooting, Technology Implementation
• Techno-Economics :
• Investment payback period around 3 years for a plant at processing capacity of 1 ton of trimming waste per year. Higher processing capacity will yield fast returns

Amiprojil-Paste/Powder

Technology Outline

AMIPROJIL-will be available in the form of both paste or powder

• It is the product targeting all types of infected wounds
• The product provide coolness and reduces the 0th hour pain and irritation
• The ingredients are approved by FDA
• The process of preparations employ green methods and does not generate any toxic intermediates
• The product is cyto as well as hemo compatibility
• The product accelerates healing in addition to combat the infections

Salient Features/ Highlights/ Advantages

• The Burn or infected wounds have much irritation and pain. The early hours pain has not been addressed by the existing technologies.
• The product AMIPROJIL target the early hours irritation and pain through its inherent cooling property

Business Case and Translation Status

Clinical Trails are under progress. (The technology is ready comme-rcialization).